Dynavax Technologies Corp
DVAXDelisted Feb 10, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001029142
Dynavax Technologies Corp was delisted on Feb 10, 2026; its insiders filed their last Form 4 on Feb 11, 2026; 267 institutions reported holding it in 13F filings for Q4 2025, worth $1.73B in total; Soros Fund Management was the only superinvestor holding it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 267
- Q4 2025, +6 vs. previous quarter
- 13F value
- $1.73B
- Reported value at the end of Q4 2025
- Superinvestors holding
- 1
- At the end of Q4 2025
Superinvestors holding DVAX, Q4 2025
1 superinvestor reports holding Dynavax Technologies Corp on Form 13F. Percentages are the stock's share of each portfolio.
Soros Fund Management
George Soros
0.3%
Dynavax Technologies Corp's share of the portfolio
- Shares
- 1,569,507
- Value
- $24.1M
Latest insider trades
Open-market purchases and sales by Dynavax Technologies Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 20, 2026 (view filing) | Jan 15 | 5 days | Novack David FPresident & COO | SSale | −114.0K | $15.64 | −$1.78M | −64.3%63.3K after | |
| Dec 29, 2025 (view filing) | Dec 24 | 5 days | Novack David FPresident & COO | SSale | −30.0K | $15.49 | −$464.7K | −21.2%111.5K after | |
| Aug 25, 2025 (view filing) | Aug 22 | 3 days | Myers Scott DunsethDirector | PPurchase | +3.80K | $10.82 | +$41.1K | +12.2%35.0K after | |
| Aug 22, 2025 (view filing)8:49 PM ET | Aug 21-22 | 1 day | Kroin David and 2 others10% Owner | SSaleCommon Stock, par value $0.001 per share | −2.07M | $10.82 | −$22.4M | −11.6%15.7M after | 2 lots |
| Mar 26, 2025 (view filing) | Mar 24 | 2 days | Novack David FPresident & COO | SSale | −10.0K | $14.00 | −$140.0K | −55.3%8.08K after | 10b5-1 |
| Mar 20, 2025 (view filing) | Mar 18 | 2 days | Novack David FPresident & COO | SSale | −14.0K | $13.58 | −$190.4K | −63.4%8.08K after | 10b5-1 |
| Mar 10, 2025 (view filing) | Mar 7 | 3 days | Novack David FPresident & COO | SSale | −32.8K | $14.39 | −$471.5K | −59.7%22.1K after | 10b5-1 |
| Jun 3, 2024 (view filing) | May 31 | 3 days | Cano FrancisDirector | SSale | −3.62K | $11.93 | −$43.1K | −8.9%36.9K after | |
| Mar 4, 2024 (view filing) | Mar 1 | 3 days | Burgess JustinChief Accounting Officer | SSale | −20.5K | $12.78 | −$262.3K | −100.0%0 after | 2 lots |
| Jan 8, 2024 (view filing) | Jan 4 | 4 days | Janssen RobertSVP and CMO | SSale | −1.50K | $15.00 | −$22.5K | −2.9%49.9K after | 10b5-1 |
Top 10 13F holders, Q4 2025
The largest institutional positions in Dynavax Technologies Corp at the end of Q4 2025; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 16,307,312 | $250.8M | 0.00% | +58,077+0.4% | Added |
| Deep Track Capital, LP | 15,726,349 | $241.9M | 5.52% | 00.0% | Unchanged |
| Vanguard Group Inc | 8,027,448 | $123.5M | 0.00% | −72,310−0.9% | Reduced |
| State Street Corp | 7,164,163 | $110.2M | 0.00% | +878,686+14.0% | Added |
| Chicago Capital, LLC | 3,469,580 | $53.4M | 1.32% | −839,222−19.5% | Reduced |
| Renaissance Technologies LLC | 3,337,533 | $51.3M | 0.08% | +198,986+6.3% | Added |
| Dimensional Fund Advisors LP | 3,011,086 | $46.3M | 0.01% | −556,166−15.6% | Reduced |
| Marshall Wace, LLP | 2,509,769 | $38.6M | 0.04% | +473,766+23.3% | Added |
| Geode Capital Management, LLC | 2,415,065 | $37.1M | 0.00% | −115,338−4.6% | Reduced |
| Goldman Sachs Group Inc | 2,153,979 | $33.1M | 0.00% | +291,423+15.6% | Added |